메뉴 건너뛰기




Volumn 229, Issue 8, 2004, Pages 857-863

Tetrathiomolybdate therapy protects against concanavalin A and carbon tetrachloride hepatic damage in mice

Author keywords

Cirrhosis; Copper; Hepatitis; Interleukin 1 ; Transforming growth factor

Indexed keywords

AMINOLEUCINE TRANSFERASE; AMINOTRANSFERASE; CARBON TETRACHLORIDE; CONCANAMYCIN A; HYDROXYPROLINE; INTERLEUKIN 1BETA; TETRATHIOMOLYBDIC ACID; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

EID: 4444338573     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020422900820     Document Type: Article
Times cited : (37)

References (32)
  • 2
    • 0037337399 scopus 로고    scopus 로고
    • Treatment of Wilson's disease with tetrathiomolybdate III: Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy
    • Brewer GJ, Hedera P, Kluin KJ, Carlson MD, Askari F, Dick RB, Sitterly JA, Fink JK. Treatment of Wilson's disease with tetrathiomolybdate III: initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60:378-385, 2003.
    • (2003) Arch Neurol , vol.60 , pp. 378-385
    • Brewer, G.J.1    Hedera, P.2    Kluin, K.J.3    Carlson, M.D.4    Askari, F.5    Dick, R.B.6    Sitterly, J.A.7    Fink, J.K.8
  • 4
    • 0035073521 scopus 로고    scopus 로고
    • The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma
    • Cox CD, Teknos TN, Barrios M, Brewer GJ, Dick RD, Merajver SD. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 111:696-701, 2001.
    • (2001) Laryngoscope , vol.111 , pp. 696-701
    • Cox, C.D.1    Teknos, T.N.2    Barrios, M.3    Brewer, G.J.4    Dick, R.D.5    Merajver, S.D.6
  • 6
    • 0036708501 scopus 로고    scopus 로고
    • Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma
    • van Golen K, Bao L, Brewer G, Pienta K, Karadt J, Livant D, Merajver S. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia 4:373-379, 2002.
    • (2002) Neoplasia , vol.4 , pp. 373-379
    • Van Golen, K.1    Bao, L.2    Brewer, G.3    Pienta, K.4    Karadt, J.5    Livant, D.6    Merajver, S.7
  • 7
    • 1642499579 scopus 로고    scopus 로고
    • An anticopper antiangiogenic approach for advanced cancer in spontaneously occurring tumors, using tetrathiomolybdate: A pilot study in a canine animal model
    • Kent MS, Madewell BR, Dank G, Dick R, Merajver SD, Brewer GJ. An anticopper antiangiogenic approach for advanced cancer in spontaneously occurring tumors, using tetrathiomolybdate: a pilot study in a canine animal model. J Trace Elem Exp Med 17:9-20, 2004.
    • (2004) J Trace Elem Exp Med , vol.17 , pp. 9-20
    • Kent, M.S.1    Madewell, B.R.2    Dank, G.3    Dick, R.4    Merajver, S.D.5    Brewer, G.J.6
  • 9
    • 0034937998 scopus 로고    scopus 로고
    • Copper control as an antiangiogenic anticancer therapy: Lessons from treating Wilson's disease
    • Brewer GJ. Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease. Exp Biol Med 226:665-673, 2001.
    • (2001) Exp Biol Med , vol.226 , pp. 665-673
    • Brewer, G.J.1
  • 10
    • 0141799951 scopus 로고    scopus 로고
    • Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis, and inflammation
    • Brewer GJ. Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis, and inflammation. J Cell Mol Med 7:11-20, 2003.
    • (2003) J Cell Mol Med , vol.7 , pp. 11-20
    • Brewer, G.J.1
  • 11
  • 13
    • 0028109801 scopus 로고
    • Transforming growth factor beta in tissue fibrosis
    • Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331:1286-1292, 1994.
    • (1994) N Engl J Med , vol.331 , pp. 1286-1292
    • Border, W.A.1    Noble, N.A.2
  • 14
    • 0032873465 scopus 로고    scopus 로고
    • Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: Down-regulation by cAMP
    • Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor β-induced collagen synthesis: down-regulation by cAMP. FASEB J 13:1774-1786, 1999.
    • (1999) FASEB J , vol.13 , pp. 1774-1786
    • Duncan, M.R.1    Frazier, K.S.2    Abramson, S.3    Williams, S.4    Klapper, H.5    Huang, X.6    Grotendorst, G.R.7
  • 15
    • 0026597574 scopus 로고
    • Lung cytokine production in bleomycin-induced pulmonary fibrosis
    • Phan SH, Kunkel SL. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 18:29-43, 1992.
    • (1992) Exp Lung Res , vol.18 , pp. 29-43
    • Phan, S.H.1    Kunkel, S.L.2
  • 16
    • 0032787927 scopus 로고    scopus 로고
    • The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family
    • Brigstock DR. The connective tissue growth factor/cysteine-rich 61/ nephroblastoma overexpressed (CCN) family. Endocr Rev 20:189-206, 1999.
    • (1999) Endocr Rev , vol.20 , pp. 189-206
    • Brigstock, D.R.1
  • 17
    • 0013241440 scopus 로고    scopus 로고
    • Tetrathiomolybdate anticopper therapy protects against bleomycin-pulmonary fibrosis in mice
    • Brewer GJ, Phan S. Tetrathiomolybdate anticopper therapy protects against bleomycin-pulmonary fibrosis in mice. J Invest Med 50:227A, 2002.
    • (2002) J Invest Med , vol.50
    • Brewer, G.J.1    Phan, S.2
  • 18
    • 0037342259 scopus 로고    scopus 로고
    • Tetrathiomolybdate therapy protects against bleomycin-pulmonary fibrosis in mice
    • Brewer GJ, Ullenbruch MR, Dick R, Olivarez L, Phan SH. Tetrathiomolybdate therapy protects against bleomycin-pulmonary fibrosis in mice. J Lab Clin Med 141:210-216, 2003.
    • (2003) J Lab Clin Med , vol.141 , pp. 210-216
    • Brewer, G.J.1    Ullenbruch, M.R.2    Dick, R.3    Olivarez, L.4    Phan, S.H.5
  • 19
    • 0034869412 scopus 로고    scopus 로고
    • Macrophage inflammatory protein-2 induced by TNF-α plays a pivotal role in concanavalin A-induced liver injury in mice
    • Nakamura K, Okada M, Yoneda M, Takamoto S, Nakade Y, Tamori K, Aso K, Makino I. Macrophage inflammatory protein-2 induced by TNF-α plays a pivotal role in concanavalin A-induced liver injury in mice. J Hepatol 35:217-224, 2001.
    • (2001) J Hepatol , vol.35 , pp. 217-224
    • Nakamura, K.1    Okada, M.2    Yoneda, M.3    Takamoto, S.4    Nakade, Y.5    Tamori, K.6    Aso, K.7    Makino, I.8
  • 23
    • 0036594572 scopus 로고    scopus 로고
    • Tumor necrosis factor-α blockade: A novel therapy for rheumatic disease
    • Shanahan CS, St. Clair EW. Tumor necrosis factor-α blockade: a novel therapy for rheumatic disease. Clin Immunol 103:231-242, 2002.
    • (2002) Clin Immunol , vol.103 , pp. 231-242
    • Shanahan, C.S.1    St. Clair, E.W.2
  • 26
    • 0035083651 scopus 로고    scopus 로고
    • Treatment of psoriatic arthritis with anti-tumor necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate
    • Ogilvie AL, Atoni C, Dechant C, Manger B, Kalden JR, Schuler G, Luftl M. Treatment of psoriatic arthritis with anti-tumor necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate. Br J Dermatol 144:587-589, 2001.
    • (2001) Br J Dermatol , vol.144 , pp. 587-589
    • Ogilvie, A.L.1    Atoni, C.2    Dechant, C.3    Manger, B.4    Kalden, J.R.5    Schuler, G.6    Luftl, M.7
  • 27
    • 0035832515 scopus 로고    scopus 로고
    • Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomized trial
    • Chaudhari U, Roman P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial. Lancet 357:1842-1847, 2001.
    • (2001) Lancet , vol.357 , pp. 1842-1847
    • Chaudhari, U.1    Roman, P.2    Mulcahy, L.D.3    Dooley, L.T.4    Baker, D.G.5    Gottlieb, A.B.6
  • 28
    • 0034729950 scopus 로고    scopus 로고
    • Etanercept in the treatment of psoriatic arthritis and psoriasis: A randomized trial
    • Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet 35:385-390, 2000.
    • (2000) Lancet , vol.35 , pp. 385-390
    • Mease, P.J.1    Goffe, B.S.2    Metz, J.3    VanderStoep, A.4    Finck, B.5    Burge, D.J.6
  • 29
    • 0034022166 scopus 로고    scopus 로고
    • TGF-β influences the life and death decisions of T lymphocytes
    • Wahl SM, Orenstein JM, Chen W. TGF-β influences the life and death decisions of T lymphocytes. Cytokine Growth Factor Rev 11:71-79, 2000.
    • (2000) Cytokine Growth Factor Rev , vol.11 , pp. 71-79
    • Wahl, S.M.1    Orenstein, J.M.2    Chen, W.3
  • 31
    • 0036987742 scopus 로고    scopus 로고
    • Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration
    • Vine AK, Brewer GJ. Tetrathiomolybdate as an antiangiogenesis therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. Trans Am Ophthalmol Soc 100:73-76, 2002.
    • (2002) Trans Am Ophthalmol Soc , vol.100 , pp. 73-76
    • Vine, A.K.1    Brewer, G.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.